Uncommon Therapeutics Analysis
What is Uncommon Therapeutics?
uncommon therapeutics develops drugs for rare diseases, starting with Rett Syndrome. The company says it uses the latest technologies and deep disease expertise to validate modalities and move candidates into the clinic with focused capital. Its site claims the approach has already unlocked multiple therapeutics that could improve patient lives and possibly deliver a cure.
Location
San Francisco, United States
Employees
1-10
Founded
2024
Description (YC)
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Tag (YC)
Healthcare
Product Features & Capabilities
- therapeutics for rare genetic diseases, focus on Rett Syndrome, innovative polytherapy strategy, combination therapies aimed at delivering a cure, AI-driven drug discovery.
See something that needs updating? Suggest edits to this profile.